Correlation Between PepGen and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both PepGen and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PepGen and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PepGen and Protara Therapeutics, you can compare the effects of market volatilities on PepGen and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PepGen with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PepGen and Protara Therapeutics.
Diversification Opportunities for PepGen and Protara Therapeutics
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between PepGen and Protara is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding PepGen and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and PepGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PepGen are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of PepGen i.e., PepGen and Protara Therapeutics go up and down completely randomly.
Pair Corralation between PepGen and Protara Therapeutics
Given the investment horizon of 90 days PepGen is expected to generate 1.87 times less return on investment than Protara Therapeutics. In addition to that, PepGen is 1.34 times more volatile than Protara Therapeutics. It trades about 0.03 of its total potential returns per unit of risk. Protara Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest 137.00 in Protara Therapeutics on September 1, 2024 and sell it today you would earn a total of 164.00 from holding Protara Therapeutics or generate 119.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
PepGen vs. Protara Therapeutics
Performance |
| Timeline |
| PepGen |
| Protara Therapeutics |
PepGen and Protara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PepGen and Protara Therapeutics
The main advantage of trading using opposite PepGen and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PepGen position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.| PepGen vs. Pmv Pharmaceuticals | PepGen vs. Eliem Therapeutics | PepGen vs. MediciNova | PepGen vs. Pharvaris BV |
| Protara Therapeutics vs. Tff Pharmaceuticals | Protara Therapeutics vs. Eliem Therapeutics | Protara Therapeutics vs. Inhibrx | Protara Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |